SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Divi's Laboratories reports 68% rise in Q4 consolidated net profit

27 May 2024 Evaluate

Divi's Laboratories has reported results for fourth quarter (Q4) and year ended March 31, 2024.

The company has reported 66.46% rise in its net profit at Rs 531 crore for the quarter under review as compared to Rs 319 crore for the same quarter in the previous year. Total income of the company increased by 18.44% at Rs 2,338 crore for Q4FY24 as compared Rs 1,974 crore for the corresponding quarter previous year.

On consolidated basis, the company has reported 67.60% rise in its net profit at Rs  538 crore for fourth quarter ended March 31, 2024 as compared to Rs 321 crore for the same quarter in the previous year. Total income of the company increased by 18.10% at Rs 2,382 crore for Q4FY24 as compared Rs 2,017 crore for the corresponding quarter previous year.

For the year ended March 31, 2024, the company has reported 12.83% fall in its net profit at Rs 1,576 crore as compared to Rs 1,808 crore for the previous year. However, total income of the company increased by 0.35% at Rs 8,002 crore for year under review as compared to Rs 7,974 crore for year ended March 31, 2023.

For the year ended March 31, 2024, on the consolidated basis, the company has reported 12.28% fall in its net profit at Rs 1,600 crore as compared to Rs 1,824 crore for the previous year. However, total income of the company increased by 0.89% at Rs 8,184 crore for year under review as compared to Rs 8,112 crore for year ended March 31, 2023.

Divis Lab Share Price

6284.50 3.15 (0.05%)
21-Apr-2026 09:27 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1677.90
Dr. Reddys Lab 1230.00
Cipla 1229.00
Zydus Lifesciences 932.15
Lupin 2333.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×